Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP‐43‐positive inclusions of amyotrophic lateral sclerosis
暂无分享,去创建一个
H. Ito | H. Kusaka | S. Kaneko | Y. Nakamura | M. Nakamura | R. Wate | S. Asayama | K. Fujita
[1] S. Nakano,et al. Smad ubiquitination regulatory factor‐2 in progressive supranuclear palsy , 2011, Neuropathology and applied neurobiology.
[2] Hiroaki Suzuki,et al. TDP-43-induced Death Is Associated with Altered Regulation of BIM and Bcl-xL and Attenuated by Caspase-mediated TDP-43 Cleavage* , 2011, The Journal of Biological Chemistry.
[3] T. Hortobágyi,et al. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. , 2010, Brain : a journal of neurology.
[4] F. He,et al. Smad Ubiquitylation Regulatory Factor 1/2 (Smurf1/2) Promotes p53 Degradation by Stabilizing the E3 Ligase MDM2* , 2010, The Journal of Biological Chemistry.
[5] G. Sobue,et al. Disrupted Transforming Growth Factor-β Signaling in Spinal and Bulbar Muscular Atrophy , 2010, The Journal of Neuroscience.
[6] S. Nakano,et al. Nuclear Contour Irregularity and Abnormal Transporter Protein Distribution in Anterior Horn Cells in Amyotrophic Lateral Sclerosis , 2009, Journal of neuropathology and experimental neurology.
[7] J. Wrana,et al. Regulation of Planar Cell Polarity by Smurf Ubiquitin Ligases , 2009, Cell.
[8] J. Trojanowski,et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2008, The American journal of pathology.
[9] S. Nakano,et al. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model , 2008, Acta Neuropathologica.
[10] S. Love,et al. Phosphorylated Smad 2/3 Colocalizes With Phospho-tau Inclusions in Pick Disease, Progressive Supranuclear Palsy, and Corticobasal Degeneration but Not With α-Synuclein Inclusions in Multiple System Atrophy or Dementia With Lewy Bodies , 2007, Journal of neuropathology and experimental neurology.
[11] S. Love,et al. Neurofibrillary Tangles May Interfere With Smad 2/3 Signaling in Neurons , 2007, Journal of neuropathology and experimental neurology.
[12] H. Akiyama,et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.
[13] G. Perry,et al. Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway? , 2006, Journal of neuroscience research.
[14] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[15] T. Arendt,et al. Altered subcellular location of phosphorylated Smads in Alzheimer's disease , 2006, The European journal of neuroscience.
[16] S. Nakano,et al. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis , 2006, Acta Neuropathologica.
[17] P. Robinson,et al. The Role of Ubiquitin-Protein Ligases in Neurodegenerative Disease , 2004, Neurodegenerative Diseases.
[18] P. Dijke,et al. New insights into TGF-β–Smad signalling , 2004 .
[19] R. Derynck,et al. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Wrana,et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.
[21] Xia Lin,et al. Smurf2 Is a Ubiquitin E3 Ligase Mediating Proteasome-dependent Degradation of Smad2 in Transforming Growth Factor-β Signaling* 210 , 2000, The Journal of Biological Chemistry.
[22] Jeffrey L. Wrana,et al. TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling* , 1997, The Journal of Biological Chemistry.
[23] John Calvin Reed,et al. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. , 1996, Molecular pharmacology.
[24] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[25] C. Hill,et al. New insights into TGF-beta-Smad signalling. , 2004, Trends in biochemical sciences.